While the world focuses on COVID-19, this article provides insight on the current state of the market for antimicrobial resistant (AMR) medicines.
Michael K. O’Brien, PhD
Advertisement
Articles by Michael K. O’Brien, PhD
Advertisement
Latest Updated Articles
- A Market Failure for Antimicrobial Resistant Medicines
Published: July 8th 2020 | Updated:
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
